AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 1 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $10,192,000 | +104.0% | 295,848 | -1.1% | 0.13% | +90.0% |
| Q2 2020 | $4,996,000 | +14.1% | 298,996 | -1.5% | 0.07% | -9.1% |
| Q1 2020 | $4,378,000 | -50.7% | 303,581 | +14.4% | 0.08% | -35.3% |
| Q4 2019 | $8,883,000 | +53.1% | 265,402 | -4.2% | 0.12% | +45.1% |
| Q3 2019 | $5,802,000 | +41.7% | 277,064 | +40.9% | 0.08% | +32.3% |
| Q2 2019 | $4,094,000 | -7.8% | 196,618 | -1.0% | 0.06% | -13.9% |
| Q1 2019 | $4,441,000 | -18.9% | 198,692 | -13.2% | 0.07% | -33.3% |
| Q4 2018 | $5,473,000 | +7.8% | 228,820 | +22.9% | 0.11% | +31.7% |
| Q3 2018 | $5,079,000 | – | 186,193 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 3,100,146 | $117,248,000 | 40.96% |
| TLP GROUP LLC | 1,050,000 | $39,711,000 | 27.53% |
| Aisling Capital LLC | 2,240,000 | $84,717,000 | 16.74% |
| Foresite Capital Management III, LLC | 764,824 | $28,926,000 | 8.12% |
| AlpInvest Partners B.V. | 51,498 | $1,948,000 | 6.95% |
| Vivo Capital, LLC | 643,626 | $24,342,000 | 5.21% |
| GREAT POINT PARTNERS LLC | 573,550 | $21,692,000 | 3.70% |
| Eventide Asset Management | 1,226,000 | $46,367,000 | 2.42% |
| Palo Alto Investors LP | 1,146,419 | $43,358,000 | 1.87% |
| HAMILTON LANE ADVISORS LLC | 78,846 | $2,982,000 | 1.54% |